Heartland is recognized and contractually funded by the State of Texas to provide excellence, expertise, and innovation in training, medical consultation, and product development to reduce the impact of tuberculosis throughout the State of Texas.
Join our TB experts as they discuss epidemiological TB trends in Texas and migrant populations; state laboratory updates and innovations on the horizon; TB in vulnerable populations; TB initiatives in Texas; and the importance of providing patient-centered care for improved healthcare outcomes. To view the recording of the webcast, visit the Heartland National TB Center's official YouTube Channel.
Tuberculosis is an infectious disease that affects millions of lives each year across the country and around the globe. Learn more about TB from some of the brave survivors who share their experiences from their diagnoses to their triumphs and more by clicking on the image above and checking out the personal stories hosted on the CDC website.
Elizabeth Reyes, 30, has become familiar with the dreadful symptoms of TB. She’s been battling the illness for 17 months and has been an admitted patient for a year at San Antonio’s TCID, 200 miles from her home in Houston. To this day, she has no idea how she caught TB.
Join our Mailing List!
CDC Announces Updates to Provisional Guidance for the Use of Pretomanid as Part of BPaL Regimen to Treat Drug-Resistant Tuberculosis
On May 4, 2023, a Dear Colleague letter from the CDC titled "Updates to CDC Provisional Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease" was sent out announcing updates to a document with the same title that had gone online on February 2, 2022. Substantive changes were made that differ from the February 2, 2022 version regarding these guidelines, so click on the image above to see a detailed breakdown of the updates from the CDC website.